Breast Cancer Clinical Trial
Localization of Intercostal Perforating Vessels Reduces Wound Complications From Nipple Sparing Mastectomy
Summary
Approximately 100 women scheduled for NSM will be consented pre-operatively to participate in the study. US will be performed after induction of general anesthesia, prior to surgery using Sonositeâ„¢ portable US, 5-12mHz transducer using doppler mode.
Full Description
Nipple Sparing Mastectomy (NSM) has been increasingly utilized over the last ten years for risk-reducing surgery and surgical treatment for breast cancer. The oncologic safety has been well established in multiple studies in appropriately selected individuals. Additionally, rates of wound complications and risk factors for wound problems are well documented. The intercostal perforating vessels (IPV) have been demonstrated to provide a significant proportion of the blood supply to the nipple-areolar complex1-3. Thus, preservation of these vessels is essential to reducing ischemic necrosis of the nipple-areolar complex. We propose that localization of these vessels utilizing intra-operative ultrasound (US) will reduce ischemic necrosis complications of NSM.
Objectives
Demonstrate that US is an effective means of localizing the IPV intraoperatively.
Evaluate the frequency of IPV preservation with the use of US.
Measure rate and severity of ischemic necrosis when US is utilized to preserve IPV.
Compare observed rate with historical controls.
Eligibility Criteria
Inclusion Criteria:
Females 18 years of age or older
Planned nipple sparing mastectomy
Exclusion Criteria:
Contraindication to nipple sparing mastectomy
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Elk Grove Village Illinois, 60007, United States
How clear is this clinincal trial information?